Eli Lilly (LLY) stock vs the S&P 500 and pharmaceutical stocks
As of 20 November 2026, Eli Lilly (LLY) is beating both the S&P 500 and pharmaceutical stocks as a group (PPH) over the past three months.
Where Eli Lilly stands now
As of 20 November 2026, Eli Lilly is ahead of the S&P 500 on every window Zensei tracks, from one month to one year. The trend against the market is intact on all horizons.
Inside its group, LLY leads: it is ahead of pharmaceutical stocks (PPH) over both the past month and three months. As a group, pharmaceutical stocks are gaining ground on the S&P 500 right now. The group is in transition, so the stock's place inside it matters more than usual.
Eli Lilly is 23.2% of PPH, a weight large enough to drive the fund. It sits in 3 of the sector and theme funds Zensei tracks. The thing to watch is the gap to its group: as long as it stays ahead of both the market and its peers, the trend is intact.
LLY vs the S&P 500: returns
Eli Lilly and the S&P 500 (SPY) side by side, over each window Zensei tracks.
Prices as of · computed from daily adjusted closes · how we measure
LLY against pharmaceutical stocks, in depth
See the size of the gap between Eli Lilly and pharmaceutical stocks (PPH) over every window, its momentum and its relative strength, and where it sits among pharmaceutical stocks.
See the full analysisWhich ETFs hold Eli Lilly?
3 funds that Zensei tracks hold LLY, by weight. The fund with the largest weight is its sector on this page.
Eli Lilly competitors
The largest other holdings of VanEck Pharmaceutical ETF (PPH), with their return over the past month.
Eli Lilly stock: common questions
Is Eli Lilly stock beating the S&P 500?
As of 20 November 2026, Eli Lilly (LLY) is up 5.1% over the past month. The S&P 500 is down 10.3% over the same month. Over three months, the stock is up 7.4% and the S&P 500 is down 9.7%.
Which ETFs hold Eli Lilly?
As of 20 November 2026, 3 funds that Zensei tracks hold LLY. Its largest weight is in VanEck Pharmaceutical ETF (PPH), at 23.2%. It is also in Health Care Select Sector SPDR (XLV, 16.9%), SPDR S&P 1500 Momentum Tilt ETF (MMTM, 2.6%).
Who are Eli Lilly's competitors?
As of 20 November 2026, the largest other holdings of VanEck Pharmaceutical ETF (PPH) are Merck & Co Inc (MRK), Novo Nordisk (NVO), Pfizer (PFE), Mckesson Corp (MCK), Bristol-Myers Squibb Co (BMY). These are the stocks Eli Lilly sits next to among pharmaceutical stocks.
Is Eli Lilly doing better than other pharmaceutical stocks?
As of 20 November 2026, Eli Lilly (LLY) is ahead of pharmaceutical stocks as a group (PPH) over the past three months. Zensei Edge shows the size of the gap, its momentum and its relative strength.
Recent changes
- ·Among the strongest → beating the market and pharmaceutical stocks
- ·Beating the market and pharmaceutical stocks → among the strongest
- ·Among the strongest → beating the market and pharmaceutical stocks
- ·Beating the market and pharmaceutical stocks → among the strongest
- ·Beating the market, trailing pharmaceutical stocks → beating the market and pharmaceutical stocks
Track Eli Lilly against pharmaceutical stocks and the market
Zensei Edge maps 100+ sectors and themes against the S&P 500, with each stock inside them measured against its group.